Trials / Completed
CompletedNCT01580605
French National Registry of Adults With Growth Hormone Deficiency Treated With Somatropin
Prospective, Longitudinal and National Follow-up Program of Adult Patients With Somatotropic Hormone Deficiency for Whom Substituting Treatment by Norditropin SimpleXx Was Started
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 331 (actual)
- Sponsor
- Novo Nordisk A/S · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study is conducted in Europe. The aim of this study is to extract data from the French National Registry holding information about patients having initiated growth hormone therapy with the objective to describe patients receiving growth hormone therapy, assess efficacy and safety of somatropin (Norditropin® SimpleXx®) and evaluate treatment compliance.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | somatropin | Data are extracted from the French National Registry "l'Observatoire National des Prescriptions et Consommations de Médicaments" to where physicians report data about growth hormone treatment |
Timeline
- Start date
- 2003-07-17
- Primary completion
- 2011-11-28
- Completion
- 2011-11-28
- First posted
- 2012-04-19
- Last updated
- 2019-11-12
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01580605. Inclusion in this directory is not an endorsement.